ComplianceOnline

FDA Issues Draft Guidance for Increasing Women Representation in Medical Device Clinical Trials

  • By: Staff Editor
  • Date: December 29, 2011
Webinar All Access Pass Subscription Abstract:

The FDA has issued a draft guidance that aims at increasing the representation of women in medical device clinical trials. Aimed at medical device manufacturers and developers, the guidance outlines agency recommendations for designing and conducting device clinical studies that may enhance the enrollment of women in such studies, if appropriate.

This article gives an overview and summary of recommendations included in this FDA draft guidance.
 

Bookmark and Share

Compliance Trainings

Risk Based Monitoring for GCP Compliance
By - Laura Brown
On Demand Access Anytime

Compliance Standards

Best Sellers
You Recently Viewed
    Loading